ClinicalTrials.Veeva

Menu

Ocular Manifestations of Inflammatory Bowel Disease

C

Central Hospital, Nancy, France

Status

Completed

Conditions

Ophthalmopathy
Inflammatory Bowel Diseases

Treatments

Other: reason for consultation

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Ocular damage is found in the 3rd rank of extra intestinal manifestations (MEI) Potentially serious functional complications (see uveitis and risk of blindness) requiring rapid management Rare uveitis in the literature (0.5% -3%), study on a large sample to assess their prevalence in patients with IBD at the Nancy CHRU and describe all the ocular manifestations that can be found.

Enrollment

87 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients followed at Nancy University Hospital for IBD and having consulted in the ophthalmology department

Exclusion criteria

  • Minor patients
  • patients without IBD
  • patients for whom there is no ophthalmology consultation

Trial design

87 participants in 1 patient group

patients with chronic inflammatory bowel disease who consulted in ophthalmology
Treatment:
Other: reason for consultation

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems